118 related articles for article (PubMed ID: 8943386)
21. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
22. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
[TBL] [Abstract][Full Text] [Related]
23. Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma.
Sriskandan S; Evans TJ; Cohen J
J Immunol; 1996 Apr; 156(7):2430-5. PubMed ID: 8786301
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
25. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
26. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.
Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR
J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399
[TBL] [Abstract][Full Text] [Related]
27. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
Verhoef A; Lamb JR
J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
[TBL] [Abstract][Full Text] [Related]
28. A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies.
Viola A; Linkert S; Lanzavecchia A
Eur J Immunol; 1997 Nov; 27(11):3080-3. PubMed ID: 9394839
[TBL] [Abstract][Full Text] [Related]
29. Identification of Dermatophagoides farinae-2-derived peptides and class II HLA molecules recognized by T cells from atopic individuals.
Inoue R; Matsuoka T; Kondo N; Nishimura Y; Matsushita S
Int Arch Allergy Immunol; 1997 Dec; 114(4):354-60. PubMed ID: 9414139
[TBL] [Abstract][Full Text] [Related]
30. B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.
Wijesuriya R; Maruo S; Zou JP; Ogawa M; Umehara K; Yamashita M; Ono S; Fujiwara H; Hamaoka T
Int Immunol; 1998 Aug; 10(8):1057-65. PubMed ID: 9723691
[TBL] [Abstract][Full Text] [Related]
31. Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergy.
Min B; Legge KL; Bell JJ; Gregg RK; Li L; Caprio JC; Zaghouani H
J Immunol; 2001 May; 166(9):5594-603. PubMed ID: 11313399
[TBL] [Abstract][Full Text] [Related]
32. Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones.
Fasler S; Aversa G; de Vries JE; Yssel H
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):521-30. PubMed ID: 9564806
[TBL] [Abstract][Full Text] [Related]
33. IL 1 induction by murine T cell clones: detection of an IL 1-inducing lymphokine.
Takacs L; Berzofsky JA; York-Jolley J; Akahoshi T; Blasi E; Durum SK
J Immunol; 1987 Apr; 138(7):2124-31. PubMed ID: 3494059
[TBL] [Abstract][Full Text] [Related]
34. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.
Itoh Y; Germain RN
J Exp Med; 1997 Aug; 186(5):757-66. PubMed ID: 9271591
[TBL] [Abstract][Full Text] [Related]
35. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.
Evavold BD; Sloan-Lancaster J; Allen PM
Immunol Today; 1993 Dec; 14(12):602-9. PubMed ID: 8305133
[TBL] [Abstract][Full Text] [Related]
36. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling.
Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K
J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449
[TBL] [Abstract][Full Text] [Related]
37. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
Nishimura Y; Chen YZ; Kanai T; Yokomizo H; Matsuoka T; Matsushita S
Intern Med; 1998 Oct; 37(10):804-17. PubMed ID: 9840700
[TBL] [Abstract][Full Text] [Related]
38. Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responses.
Li L; Legge KL; Min B; Bell JJ; Gregg R; Caprio J; Zaghouani H
J Immunol; 2001 Sep; 167(5):2585-94. PubMed ID: 11509599
[TBL] [Abstract][Full Text] [Related]
39. Dermatophagoides farinae-1-derived peptides and HLA molecules recognized by T cells from atopic individuals.
Matsuoka T; Kohrogi H; Ando M; Nishimura Y; Matsushita S
Int Arch Allergy Immunol; 1997 Apr; 112(4):365-70. PubMed ID: 9104792
[TBL] [Abstract][Full Text] [Related]
40. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients.
Chougnet C; Thomas E; Landay AL; Kessler HA; Buchbinder S; Scheer S; Shearer GM
Eur J Immunol; 1998 Feb; 28(2):646-56. PubMed ID: 9521075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
